{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:17:44Z","timestamp":1793215064032,"version":"4.5.0"},"reference-count":305,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Alzheimer's disease (AD) is a gradual and irreversible decline in the brain's ability to function which is not only signified by amyloid-beta plaques and neurofibrillary tangles but also by and metabolic and mitochondrial changes that have a negative impact on the classical neuropathological hallmarks. It is becoming increasingly clear that the central roles in the process of synaptic dysfunction, neuronal death and cognitive decline are played by the brain's impaired glucose utilization, insulin resistance, lipid metabolism alterations, and energy homeostasis disruption. Mitochondrial dysfunctions in AD comprising of oxidative phosphorylation defects, ATP production decrease, reactive oxygen species generation over and above the normal level, poor mitochondrial dynamics, and vacuolar-type H+-ATPase-mediated cell death are the factors that further worsen the situation and hence speed up the process of neuronal death and eventually, disease progression. The metabolic and mitochondrial disturbances have a two-way relationship with amyloid-beta and tau pathology, neuroinflammation, and oxidative stress, thus creating a self-sustaining cycle of neurodegeneration. Besides, clinical and neuroimaging studies, fluorodeoxyglucose positron emission tomography, cerebrospinal fluid biomarkers, and peripheral metabolic profiling all support the notion that metabolic impairment is an early and clinically relevant feature of AD very convincingly. Thus, the attention of the scientific community has turned more and more toward the approaches that use the metabolic and mitochondrial pathways as their target. The new treatments are coming, including insulin sensitizers, ketogenic and Mediterranean diets, mitochondrial-targeted antioxidants, exercise, metabolic modulators, and new drugs, all aimed at bringing back equilibrium to bioenergetics and letting neurons live longer. In this review, we have considered the current mechanistic insights, clinical evidence, and therapeutic advances related to metabolic dysfunction and mitochondrial failure in AD together and their potential as early biomarkers and modifiable targets for disease prevention and treatment that are highlighted.<\/jats:p>","DOI":"10.3389\/fneur.2026.1772036","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T05:28:35Z","timestamp":1772083715000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Metabolic dysfunction and mitochondrial failure in Alzheimer's disease: integrating pathophysiology, clinical evidence and emerging interventions"],"prefix":"10.3389","volume":"17","author":[{"given":"Xiaohua","family":"Xiao","sequence":"first","affiliation":[{"name":"Geriatrics Department, Shenzhen Second People's Hospital","place":["Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqin","family":"Yan","sequence":"additional","affiliation":[{"name":"Geriatrics Department, Shenzhen Second People's Hospital","place":["Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhua","family":"Liang","sequence":"additional","affiliation":[{"name":"Geriatrics Department, Shenzhen Second People's Hospital","place":["Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunzhu","family":"Yang","sequence":"additional","affiliation":[{"name":"Geriatrics Department, Shenzhen Second People's Hospital","place":["Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.mcna.2018.10.009","article-title":"The Alzheimer's disease clinical spectrum","volume":"103","author":"Atri","year":"2019","journal-title":"Med Clin North Am."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1016\/S0140-6736(13)60221-4","article-title":"Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990\u20132010: a systematic review and analysis","volume":"381","author":"Chan","year":"2013","journal-title":"Lancet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"603854","DOI":"10.3389\/fnagi.2020.603854","article-title":"Prevalence of Alzheimer's disease and Parkinson's disease in China: an updated systematical analysis","volume":"12","author":"Cui","year":"2020","journal-title":"Front Aging Neurosci"},{"key":"B4","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2147\/NDT.S172285","article-title":"The prevalence of Alzheimer's disease in the Chinese Han population: a meta-analysis","volume":"42","author":"Zhao","year":"2018","journal-title":"Neurol Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1002\/alz.051496","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019","volume":"7","author":"Nichols","year":"2022","journal-title":"Lancet Public Health."},{"key":"B6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the Lancet Commission","volume":"396","author":"Livingston","year":"2020","journal-title":"Lancet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13024-017-0192-x","article-title":"Glial contributions to neurodegeneration in tauopathies","volume":"12","author":"Leyns","year":"2017","journal-title":"Mol Neurodegener."},{"key":"B8","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nature24016","article-title":"ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy","volume":"549","author":"Shi","year":"2017","journal-title":"Nature."},{"key":"B9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13024-017-0216-6","article-title":"TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy","volume":"12","author":"Bemiller","year":"2017","journal-title":"Molecular Neurodegener"},{"key":"B10","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","article-title":"The cellular phase of Alzheimer's disease","volume":"164","author":"De Strooper","year":"2016","journal-title":"Cell."},{"key":"B11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3390\/biomedicines9010063","article-title":"Mitochondrial dysfunction in Alzheimer's disease: a biomarker of the future?","volume":"9","author":"Bell","year":"2021","journal-title":"Biomedicines."},{"key":"B12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.neurobiolaging.2016.12.029","article-title":"Mitochondrial genes are altered in blood early in Alzheimer's disease","volume":"53","author":"Lunnon","year":"2017","journal-title":"Neurobiol Aging."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/3984906","article-title":"Suppression of Alzheimer's disease-like pathology progression by mitochondria-targeted antioxidant SKQ1: a transcriptome profiling study","volume":"2019","author":"Stefanova","year":"2019","journal-title":"Oxid Med Cell Longev."},{"key":"B14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/978-3-319-45096-4_2","article-title":"Glucose, lactate, B-Hydroxybutyrate, acetate, GABA, and succinate as substrates for synthesis of glutamate and GABA in the Glutamine\u2013Glutamate\/GABA cycle","volume":"13","author":"Hertz","year":"2016","journal-title":"Adv Neurobiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1177\/0271678X17746179","article-title":"The importance of small polar radiometabolites in molecular neuroimaging: a PET study with [11c]cimbi-36 labeled in two positions","volume":"38","author":"Johansen","year":"2017","journal-title":"J Cereb Blood Flow Metab."},{"key":"B16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4149\/endo_2014_01_35","article-title":"Glucose transport in brain \u2013 effect of inflammation","volume":"48","author":"Jurcovicova","year":"2014","journal-title":"Endocr Regul."},{"key":"B17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/B978-0-12-397179-1.00003-8","article-title":"Energy metabolism in the brain","volume-title":"From Molecules to Networks: An Introduction to Cellular and Molecular Neuroscience.","author":"Dienel","year":"2014"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-3-319-74932-7_1","article-title":"Cellular metabolism at a glance","volume":"109","author":"Mesquita","year":"2018","journal-title":"Experientia Suppl."},{"key":"B19","doi-asserted-by":"publisher","first-page":"101674","DOI":"10.1016\/j.redox.2020.101674","article-title":"Mitochondrial electron transport chain: oxidative phosphorylation, oxidant production, and methods of measurement","volume":"37","author":"Nolfi-Donegan","year":"2020","journal-title":"Redox Biol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nrn.2018.19","article-title":"Lactate in the brain: from metabolic end-product to signalling molecule","volume":"19","author":"Magistretti","year":"2018","journal-title":"Nat Rev Neurosci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.cmet.2018.03.008","article-title":"The science and translation of lactate shuttle theory","volume":"27","author":"Brooks","year":"2018","journal-title":"Cell Metab."},{"key":"B22","doi-asserted-by":"publisher","first-page":"13398","DOI":"10.3390\/ijms241713398","article-title":"Lactate metabolism, signaling, and function in brain development, synaptic plasticity, angiogenesis, and neurodegenerative diseases","volume":"24","author":"Wu","year":"2023","journal-title":"Int J Mol Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1007\/s10571-023-01335-7","article-title":"Lactate and lactylation in the brain: current progress and perspectives","volume":"43","author":"Li","year":"2023","journal-title":"Cell Mol Neurobiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11910-016-0638-5","article-title":"Cerebral lactate metabolism after traumatic brain injury","volume":"16","author":"Patet","year":"2016","journal-title":"Curr Neurol Neurosci Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"800901","DOI":"10.3389\/fnut.2022.800901","article-title":"Lactate is answerable for brain function and treating brain diseases: energy substrates and signal molecule","volume":"9","author":"Cai","year":"2022","journal-title":"Front Nutr"},{"key":"B26","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1002\/med.21712","article-title":"Mitochondria and lipid peroxidation in the mechanism of neurodegeneration: finding ways for prevention","volume":"41","author":"Angelova","year":"2020","journal-title":"Med Res Rev."},{"key":"B27","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/jnc.13486","article-title":"Bioenergetics and redox adaptations of astrocytes to neuronal activity","volume":"139","author":"Bola\u00f1os","year":"2016","journal-title":"J Neurochem."},{"key":"B28","doi-asserted-by":"publisher","first-page":"861","DOI":"10.3389\/fnins.2020.00861","article-title":"Superoxide and non-ionotropic signaling in neuronal excitotoxicity","volume":"4","author":"Wang","year":"2020","journal-title":"Front Neurosci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e1442","DOI":"10.1038\/cddis.2014.390","article-title":"Seizure activity results in calcium- and mitochondria-independent ROS production via NADPH and xanthine oxidase activation","volume":"5","author":"Kovac","year":"2014","journal-title":"Cell Death Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1042\/BST20191042","article-title":"Cellular mechanisms of complex I-associated pathology","volume":"47","author":"Abramov","year":"2019","journal-title":"Biochem Soc Trans."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1111\/jnc.15239","article-title":"Variability of mitochondrial energy balance across brain regions","volume":"157","author":"Cheng","year":"2020","journal-title":"J Neurochem."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neures.2018.09.002","volume":"145","author":"De Souza","year":"2018","journal-title":"Neurosci Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.tins.2017.01.002","article-title":"Mitophagy and Alzheimer's disease: cellular and molecular mechanisms","volume":"40","author":"Kerr","year":"2017","journal-title":"Trends Neurosci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neuron.2013.02.003","article-title":"The CAMKK2-AMPK kinase pathway mediates the synaptotoxic effects of A\u03b2 oligomers through Tau phosphorylation","volume":"78","author":"Mairet-Coello","year":"2013","journal-title":"Neuron."},{"key":"B35","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41593-018-0332-9","article-title":"Mitophagy inhibits amyloid-\u03b2 and tau pathology and reverses cognitive deficits in models of Alzheimer's disease","volume":"22","author":"Fang","year":"2019","journal-title":"Nat Neurosci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"22244","DOI":"10.1038\/srep22244","article-title":"Lost region in amyloid precursor protein (APP) through TALEN-mediated genome editing alters mitochondrial morphology","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep."},{"key":"B37","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3389\/fncel.2016.00179","article-title":"Mitochondrial dynamics decrease prior to axon degeneration induced by vincristine and are partially rescued by overexpressed cytNmnat1","volume":"10","author":"Berbusse","year":"2016","journal-title":"Front Cell Neurosci"},{"key":"B38","volume-title":"Mitochondria and Alzheimer's Disease: An Electron Microscopy Study","author":"Baloyannis","year":"2019"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1354682","DOI":"10.3389\/fmolb.2024.1354682","article-title":"Kinase signalling adaptation supports dysfunctional mitochondria in disease","volume":"11","author":"Skalka","year":"2024","journal-title":"Front Mol Biosci"},{"key":"B40","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3390\/life14020196","article-title":"Mitochondria in Alzheimer's disease pathogenesis","volume":"14","author":"Reiss","year":"2024","journal-title":"Life."},{"key":"B41","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fncel.2016.00024","article-title":"Alterations in mitochondrial quality control in Alzheimer's disease","volume":"10","author":"Cai","year":"2016","journal-title":"Front Cell Neurosci"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.3233\/JAD-220884","article-title":"Early mitochondrial defects in the 5xFAD mouse model of Alzheimer's disease","volume":"91","author":"Sharma","year":"2023","journal-title":"J Alzheimers Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"11520","DOI":"10.3390\/ijms222111520","article-title":"Disentangling mitochondria in Alzheimer's disease","volume":"22","author":"Johri","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"4850","DOI":"10.3390\/ijms22094850","article-title":"Mitochondrial dysfunction as a driver of cognitive impairment in Alzheimer's disease","volume":"22","author":"Sharma","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"4892","DOI":"10.1111\/jcmm.15194","article-title":"Mitochondrial biogenesis: an update","volume":"24","author":"Popov","year":"2020","journal-title":"J Cell Mol Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/cns.12655","article-title":"Mitochondrial dysfunction and biogenesis in neurodegenerative diseases: pathogenesis and treatment","volume":"23","author":"Golpich","year":"2016","journal-title":"CNS Neurosci Ther."},{"key":"B47","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.biopsych.2017.12.014","article-title":"Peroxisome proliferator-activated receptor gamma coactivator-1 alpha as a novel target for bipolar disorder and other neuropsychiatric disorders","volume":"83","author":"Nierenberg","year":"2018","journal-title":"Biol Psychiatry."},{"key":"B48","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3390\/cells8050488","article-title":"Amyloid beta and phosphorylated TAU-Induced defective autophagy and mitophagy in Alzheimer's disease","volume":"8","author":"Reddy","year":"2019","journal-title":"Cells."},{"key":"B49","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.bbalip.2013.11.014","article-title":"MAM (mitochondria-associated membranes) in mammalian cells: lipids and beyond","volume":"1841","author":"Vance","year":"2013","journal-title":"Biochim Biophys Acta."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.3390\/cells11121963","article-title":"Dysregulated Ca2+ Homeostasis as a central theme in neurodegeneration: lessons from Alzheimer's disease and wolfram syndrome","volume":"11","author":"Callens","year":"2022","journal-title":"Cells."},{"key":"B51","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s12035-025-05465-5","article-title":"Role of mitochondrial calcium dysregulation in Alzheimer's disease pathogenesis","volume":"63","author":"Ebrahimi","year":"2025","journal-title":"Mol Neurobiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"e623","DOI":"10.1038\/cddis.2013.145","article-title":"Amyloid-\u03b2 and Alzheimer's disease type pathology differentially affects the calcium signalling toolkit in astrocytes from different brain regions","volume":"4","author":"Grolla","year":"2013","journal-title":"Cell Death Dis."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.3233\/JAD-215182","article-title":"Calpain-Mediated alterations in astrocytes before and during amyloid chaos in Alzheimer's disease","volume":"84","author":"Schultz","year":"2021","journal-title":"J Alzheimers Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.tins.2020.10.004","article-title":"Mitochondria and calcium in Alzheimer's disease: From cell signaling to neuronal cell death","volume":"44","author":"Calvo-Rodriguez","year":"2020","journal-title":"Trends Neurosci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/j.bbamcr.2018.07.018","article-title":"Calcium signaling in Alzheimer's disease and therapies","volume":"1865","author":"Tong","year":"2018","journal-title":"Biochim Biophys Acta."},{"key":"B56","doi-asserted-by":"publisher","first-page":"8523","DOI":"10.3390\/ijms22168523","article-title":"Mitochondria-induced immune response as a trigger for neurodegeneration: a pathogen from within","volume":"22","author":"Luna-S\u00e1nchez","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1126\/science.aav4011","article-title":"VDAC oligomers form mitochondrial pores to release mtDNA fragments and promote lupus-like disease","volume":"366","author":"Kim","year":"2019","journal-title":"Science."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1083\/jcb.201801044","article-title":"Basal mitophagy is widespread in Drosophila but minimally affected by loss of Pink1 or parkin","volume":"217","author":"Lee","year":"2018","journal-title":"J Cell Biol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.freeradbiomed.2022.09.032","article-title":"Altered glucose metabolism in Alzheimer's disease: role of mitochondrial dysfunction and oxidative stress","volume":"193","author":"Dewanjee","year":"2022","journal-title":"Free Radic Biol Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.cortex.2024.07.004","article-title":"Cerebral glucose metabolism in Alzheimer's disease","volume":"179","author":"Salmon","year":"2024","journal-title":"Cortex"},{"key":"B61","doi-asserted-by":"publisher","first-page":"e70180","DOI":"10.1002\/hbm.70180","article-title":"Relationships between brain glucose metabolism patterns and impaired glycemic status: a systematic review of FDG-PET studies with a focus on Alzheimer's disease","volume":"46","author":"Soltani","year":"2025","journal-title":"Hum Brain Mapp."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.3233\/ADR-240104","article-title":"The association between brain metabolic biomarkers using 18F-FDG and cognition and vascular risk factors, as well as its usefulness in the diagnosis and staging of Alzheimer's disease","volume":"8","author":"Xiong","year":"2024","journal-title":"J Alzheimers Dis Rep."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1152\/physrev.00032.2015","article-title":"Brain insulin resistance at the crossroads of metabolic and cognitive disorders in humans","volume":"96","author":"Kullmann","year":"2016","journal-title":"Physiol Rev."},{"key":"B64","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3389\/fnins.2019.00629","article-title":"Altered insulin signaling in Alzheimer's disease brain \u2013 special emphasis on PI3K-AKT pathway","volume":"13","author":"Gabbouj","year":"2019","journal-title":"Front Neurosci"},{"key":"B65","doi-asserted-by":"publisher","first-page":"6665","DOI":"10.1523\/JNEUROSCI.2262-17.2018","article-title":"Human APOE isoforms differentially modulate brain glucose and ketone body metabolism: implications for Alzheimer's disease risk reduction and early intervention","volume":"38","author":"Wu","year":"2018","journal-title":"J Neurosci."},{"key":"B66","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","article-title":"Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease","volume":"20","author":"Butterfield","year":"2019","journal-title":"Nat Rev Neurosci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.bbadis.2013.08.013","article-title":"March separate, strike together \u2014 role of phosphorylated TAU in mitochondrial dysfunction in Alzheimer's disease","volume":"1842","author":"Eckert","year":"2013","journal-title":"Biochim Biophys Acta."},{"key":"B68","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.neuint.2017.03.018","article-title":"Brain energy metabolism spurns fatty acids as fuel due to their inherent mitotoxicity and potential capacity to unleash neurodegeneration","volume":"109","author":"Sch\u00f6nfeld","year":"2017","journal-title":"Neurochem Int"},{"key":"B69","doi-asserted-by":"publisher","first-page":"e100519","DOI":"10.1371\/journal.pone.0100519","article-title":"Human cerebrospinal fluid fatty acid levels differ between supernatant fluid and brain-derived nanoparticle fractions, and are altered in Alzheimer's disease","volume":"9","author":"Fonteh","year":"2014","journal-title":"PLoS ONE."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.3390\/ijms21041505","article-title":"Lipids and Alzheimer's disease","volume":"21","author":"Kao","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B71","doi-asserted-by":"publisher","first-page":"e1002266","DOI":"10.1371\/journal.pmed.1002266","article-title":"Association between fatty acid metabolism in the brain and Alzheimer disease neuropathology and cognitive performance: a nontargeted metabolomic study","volume":"14","author":"Snowden","year":"2017","journal-title":"PLoS Med."},{"key":"B72","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3389\/fphys.2020.00083","article-title":"Polyunsaturated fatty acid composition of cerebrospinal fluid fractions shows their contribution to cognitive resilience of a pre-symptomatic Alzheimer's disease cohort","volume":"11","author":"Fonteh","year":"2020","journal-title":"Front Physiol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.pharmthera.2018.11.006","article-title":"Synaptic dysfunction in Alzheimer's disease: mechanisms and therapeutic strategies","volume":"195","author":"Chen","year":"2018","journal-title":"Pharmacol Ther."},{"key":"B74","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.neuron.2016.03.005","article-title":"Acetylated TAU obstructs KIBRA-mediated signaling in synaptic plasticity and promotes Tauopathy-related memory loss","volume":"90","author":"Tracy","year":"2016","journal-title":"Neuron."},{"key":"B75","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nrn.2015.1","article-title":"Tau in physiology and pathology","volume":"17","author":"Wang","year":"2015","journal-title":"Nat Rev Neurosci."},{"key":"B76","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/alzrt258","article-title":"Truncated and modified amyloid-beta species","volume":"6","author":"Kummer","year":"2014","journal-title":"Alzheimers Res Ther."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/795375","article-title":"Amyloid beta: multiple mechanisms of toxicity and only some protective effects?","volume":"2014","author":"Carrillo-Mora","year":"2014","journal-title":"Oxid Med Cell Longev."},{"key":"B78","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3389\/fnagi.2018.00118","article-title":"The physiological roles of amyloid-B peptide hint at new ways to treat Alzheimer's disease","volume":"10","author":"Brothers","year":"2018","journal-title":"Front Aging Neurosci"},{"key":"B79","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s12035-012-8307-4","article-title":"From mitochondrial dysfunction to amyloid beta formation: novel insights into the pathogenesis of Alzheimer's disease","volume":"46","author":"Leuner","year":"2012","journal-title":"Mol Neurobiol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"902","DOI":"10.3389\/fphar.2019.00902","article-title":"Mitochondria as potential targets in Alzheimer disease therapy: an update","volume":"10","author":"Cenini","year":"2019","journal-title":"Front Pharmacol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.4103\/1673-5374.339473","article-title":"The \u201cmitochondrial stress responses\u201d: the \u201cDr. Jekyll and Mr Hyde\u201d of neuronal disorders","volume":"17","author":"Rimessi","year":"2022","journal-title":"Neural Regen Res."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/nm.1868","article-title":"Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease","volume":"14","author":"Du","year":"2008","journal-title":"Nat Med."},{"key":"B83","doi-asserted-by":"publisher","first-page":"10","DOI":"10.2741\/4304","article-title":"Critical analysis of Alzheimer's amyloid-beta toxicity to mitochondria","volume":"20","author":"Kaminsky","year":"2015","journal-title":"Front Biosci."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.3390\/antiox10101539","article-title":"BACE1 inhibition increases susceptibility to oxidative stress by promoting mitochondrial damage","volume":"10","author":"Francelin","year":"2021","journal-title":"Antioxidants."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1021\/bi061314n","article-title":"Surface plasmon resonance and nuclear magnetic resonance studies of ABAD\u2013 A\u03b2 interaction","volume":"46","author":"Yan","year":"2007","journal-title":"Biochemistry."},{"key":"B86","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1016\/j.neurobiolaging.2013.03.015","article-title":"Tau phosphorylation affects its axonal transport and degradation","volume":"34","author":"Rodr\u00edguez-Mart\u00edn","year":"2013","journal-title":"Neurobiol Aging."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/509654","article-title":"Mitochondrial dysfunction contributes to the pathogenesis of Alzheimer's disease","volume":"2015","author":"Cabezas-Opazo","year":"2015","journal-title":"Oxid Med Cell Longev"},{"key":"B88","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.stemcr.2019.08.011","article-title":"Pathological progression induced by the frontotemporal dementia-associated R406W TAU mutation in patient-derived IPSCs","volume":"13","author":"Nakamura","year":"2019","journal-title":"Stem Cell Rep."},{"key":"B89","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1093\/brain\/awv222","article-title":"Early maturation and distinct tau pathology in induced pluripotent stem cell-derived neurons from patients withMAPTmutations","volume":"138","author":"Iovino","year":"2015","journal-title":"Brain."},{"key":"B90","doi-asserted-by":"publisher","first-page":"7722","DOI":"10.3390\/ijms23147722","article-title":"Dysfunction of mitochondria in Alzheimer's disease: ANT and VDAC interact with toxic proteins and aid to determine the fate of brain cells","volume":"23","author":"Atlante","year":"2022","journal-title":"Int J Mol Sci."},{"key":"B91","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1038\/s41401-022-00879-6","article-title":"Mitochondrial-derived damage-associated molecular patterns amplify neuroinflammation in neurodegenerative diseases","volume":"43","author":"Lin","year":"2022","journal-title":"Acta Pharmacol Sin."},{"key":"B92","doi-asserted-by":"publisher","first-page":"102867","DOI":"10.1016\/j.autrev.2021.102867","article-title":"Dysfunctional mitochondria as critical players in the inflammation of autoimmune diseases: potential role in Sj\u00f6gren's syndrome","volume":"20","author":"Barrera","year":"2021","journal-title":"Autoimmun Rev."},{"key":"B93","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3390\/poultry2020019","article-title":"Mitigating the adverse effects of lead and cadmium heavy metals-induced oxidative stress by phytogenic compounds in poultry","volume":"2","author":"Ebrahimi","year":"2023","journal-title":"Poultry."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.bbadis.2013.09.010","article-title":"The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives","volume":"1842","author":"Swerdlow","year":"2013","journal-title":"Biochim Biophys Acta."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/s41380-018-0342-8","article-title":"Tau PET imaging in neurodegenerative tauopathies\u2014still a challenge","volume":"24","author":"Leuzy","year":"2019","journal-title":"Mol Psychiatry."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.3233\/JAD-151206","article-title":"A theoretical analysis of the synergy of amyloid and TAU in Alzheimer's disease","volume":"52","author":"Han","year":"2016","journal-title":"J Alzheimers Dis."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.3233\/JAD-170585","article-title":"Mitochondria and mitochondrial cascades in Alzheimer's disease","volume":"62","author":"Swerdlow","year":"2017","journal-title":"J Alzheimers Dis."},{"key":"B98","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1189\/jlb.3MR0416-204R","article-title":"Danger-associated molecular patterns in Alzheimer's disease","volume":"101","author":"Venegas","year":"2016","journal-title":"J Leukoc Biol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"420","DOI":"10.3389\/fimmu.2014.00420","article-title":"Metabolic reprograming in macrophage polarization","volume":"5","author":"Galv\u00e1n-Pe\u00f1a","year":"2014","journal-title":"Front Immunol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?","volume":"17","author":"Leng","year":"2020","journal-title":"Nat Rev Neurol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.cmet.2019.06.005","article-title":"A breakdown in metabolic reprogramming causes microglia dysfunction in Alzheimer's disease","volume":"30","author":"Baik","year":"2019","journal-title":"Cell Metab"},{"key":"B103","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cell.2017.07.023","article-title":"TREM2 maintains microglial metabolic fitness in Alzheimer's disease","volume":"170","author":"Ulland","year":"2017","journal-title":"Cell"},{"key":"B104","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3233\/JAD-190863","article-title":"Molecular mechanisms and genetics of oxidative stress in Alzheimer's disease","volume":"72","author":"Cioffi","year":"2019","journal-title":"J Alzheimers Dis."},{"key":"B105","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.coph.2015.10.001","article-title":"Critical role of the Mac1\/NOX2 pathway in mediating reactive microgliosis-generated chronic neuroinflammation and progressive neurodegeneration","volume":"26","author":"Chen","year":"2015","journal-title":"Curr Opin Pharmacol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.freeradbiomed.2011.10.488","article-title":"Rotenone activates phagocyte NADPH oxidase by binding to its membrane subunit gp91phox","volume":"52","author":"Zhou","year":"2012","journal-title":"Free Radic Biol Med."},{"key":"B107","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.bcp.2014.01.008","article-title":"Microglial dysfunction in brain aging and Alzheimer's disease","volume":"88","author":"Mosher","year":"2014","journal-title":"Biochem Pharmacol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3389\/fnagi.2015.00124","article-title":"Microglial cell dysregulation in brain aging and neurodegeneration","volume":"7","author":"Von Bernhardi","year":"2015","journal-title":"Front Aging Neurosci"},{"key":"B109","doi-asserted-by":"publisher","first-page":"101208","DOI":"10.1016\/j.arr.2020.101208","article-title":"Synaptic basis of Alzheimer's disease: focus on synaptic amyloid beta, P-tau and mitochondria","volume":"65","author":"John","year":"2020","journal-title":"Ageing Res Rev"},{"key":"B110","doi-asserted-by":"publisher","first-page":"e21990","DOI":"10.1002\/syn.21990","article-title":"Alzheimer's disease and metabolic syndrome: a link from oxidative stress and inflammation to neurodegeneration","volume":"71","author":"Rojas-Gutierrez","year":"2017","journal-title":"Synapse."},{"key":"B111","doi-asserted-by":"publisher","first-page":"549","DOI":"10.2147\/CIA.S74042","article-title":"Link between type 2 diabetes and Alzheimerandrsquo;s disease: from epidemiology to mechanism and treatment","volume":"10","author":"Li","year":"2015","journal-title":"Clin Interv Aging."},{"key":"B112","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s10654-017-0321-4","article-title":"The Rotterdam study: 2018 update on objectives, design and main results","volume":"32","author":"Ikram","year":"2017","journal-title":"Eur J Epidemiol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrneurol.2017.185","article-title":"Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums","volume":"14","author":"Arnold","year":"2018","journal-title":"Nat Rev Neurol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.tips.2017.10.008","article-title":"Insulin-degrading enzyme in the fight against Alzheimer's disease","volume":"39","author":"Kurochkin","year":"2017","journal-title":"Trends Pharmacol Sci."},{"key":"B115","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/jdi.12087","article-title":"Diabetes mellitus and risk of dementia: a meta-analysis of prospective observational studies","volume":"4","author":"Gudala","year":"2013","journal-title":"J Diabetes Investig."},{"key":"B116","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/292598","article-title":"Cholesterol: Its regulation and role in central nervous system disorders","volume":"2012","author":"Orth","year":"2012","journal-title":"Cholesterol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2174\/1567205013666151218150202","article-title":"The relationship between plasma AB levels, cognitive function and brain volumetrics: Sydney memory and ageing study","volume":"13","author":"Poljak","year":"2015","journal-title":"Curr Alzheimer Res."},{"key":"B118","doi-asserted-by":"publisher","first-page":"e99305","DOI":"10.1371\/journal.pone.0099305","article-title":"Rising midlife obesity will worsen future prevalence of dementia","volume":"9","author":"Nepal","year":"2014","journal-title":"PLoS ONE."},{"key":"B119","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1136\/postgradmedj-2014-132571","article-title":"Age at obesity and association with subsequent dementia: record linkage study","volume":"90","author":"Wotton","year":"2014","journal-title":"Postgrad Med J."},{"key":"B120","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s11154-014-9301-0","article-title":"Adipocyte dysfunction, inflammation and metabolic syndrome","volume":"15","author":"Kl\u00f6ting","year":"2014","journal-title":"Rev Endocr Metab Disord."},{"key":"B121","doi-asserted-by":"publisher","first-page":"602360","DOI":"10.3389\/fnhum.2020.602360","article-title":"Exploiting common aspects of obesity and Alzheimer's disease","volume":"14","author":"Tabassum","year":"2020","journal-title":"Front Hum Neurosci"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1172\/JCI126078","article-title":"Visceral adipose NLRP3 impairs cognition in obesity via IL-1R1 on CX3CR1+ cells","volume":"130","author":"Guo","year":"2020","journal-title":"J Clin Investig."},{"key":"B123","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1194\/jlr.P119000473","article-title":"High density lipoprotein and its apolipoprotein-defined subspecies and risk of dementia","volume":"61","author":"Koch","year":"2019","journal-title":"J Lipid Res."},{"key":"B124","doi-asserted-by":"publisher","first-page":"e209250","DOI":"10.1001\/jamanetworkopen.2020.9250","article-title":"Association of apolipoprotein E in lipoprotein subspecies with risk of dementia","volume":"3","author":"Koch","year":"2020","journal-title":"JAMA Netw Open."},{"key":"B125","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.jacc.2019.10.062","article-title":"Alzheimer's disease and vascular aging","volume":"75","author":"Cortes-Canteli","year":"2020","journal-title":"J Am Coll Cardiol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jalz.2019.06.2792","article-title":"Vascular dysfunction\u2014the disregarded partner of Alzheimer's disease","volume":"15","author":"Sweeney","year":"2019","journal-title":"Alzheimers Dement."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.3390\/cells9051215","article-title":"Alzheimer's disease, a lipid story: involvement of peroxisome proliferator-activated receptor \u03b1","volume":"9","author":"S\u00e1ez-Orellana","year":"2020","journal-title":"Cells."},{"key":"B128","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.1093\/brain\/aws271","article-title":"Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias","volume":"135","author":"Yarchoan","year":"2012","journal-title":"Brain."},{"key":"B129","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/s41593-018-0238-6","article-title":"Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases","volume":"21","author":"Jucker","year":"2018","journal-title":"Nat Neurosci."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","article-title":"The Microbiota-Gut-Brain axis","volume":"99","author":"Cryan","year":"2019","journal-title":"Physiol Rev."},{"key":"B131","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3233\/JAD-160926","article-title":"Altered gut microbiome composition and tryptic activity of the 5xFAD Alzheimer's mouse model","volume":"56","author":"Brandscheid","year":"2016","journal-title":"J Alzheimers Dis."},{"key":"B132","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3233\/JAD-160884","article-title":"Alzheimer's disease histological and behavioral manifestations in transgenic mice correlate with specific gut microbiome state","volume":"56","author":"Shen","year":"2016","journal-title":"J Alzheimers Dis."},{"key":"B133","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/14737175.2018.1400909","article-title":"Protective roles of intestinal microbiota derived short chain fatty acids in Alzheimer's disease-type beta-amyloid neuropathological mechanisms","volume":"18","author":"Ho","year":"2017","journal-title":"Expert Rev Neurother."},{"key":"B134","doi-asserted-by":"publisher","first-page":"8642","DOI":"10.18632\/aging.102352","article-title":"Decreased levels of circulating trimethylamine N-oxide alleviate cognitive and pathological deterioration in transgenic mice: a potential therapeutic approach for Alzheimer's disease","volume":"11","author":"Gao","year":"2019","journal-title":"Aging."},{"key":"B135","doi-asserted-by":"publisher","first-page":"102","DOI":"10.5498\/wjp.v2.i6.102","article-title":"Platelets and Alzheimer's disease: potential of APP as a biomarker","volume":"2","author":"Evin","year":"2012","journal-title":"World J Psychiatry."},{"key":"B136","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nn.4492","volume":"20","author":"Zimmer","year":"2017","journal-title":"Nat Neurosci."},{"key":"B137","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.neuroimage.2011.12.038","article-title":"The neurochemical profile quantified by in vivo 1H NMR spectroscopy","volume":"61","author":"Duarte","year":"2011","journal-title":"Neuroimage."},{"key":"B138","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1016\/j.neubiorev.2013.08.004","article-title":"Magnetic resonance spectroscopy in mild cognitive impairment: systematic review and meta-analysis","volume":"37","author":"Tumati","year":"2013","journal-title":"Neurosci Biobehav Rev."},{"key":"B139","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3233\/JAD-143225","article-title":"Magnetic resonance spectroscopy in Alzheimer's disease: systematic review and meta-analysis","volume":"46","author":"Wang","year":"2015","journal-title":"J Alzheimers Dis."},{"key":"B140","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/gim.2014.177","article-title":"Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society","volume":"17","author":"Parikh","year":"2014","journal-title":"Genet Med."},{"key":"B141","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s11011-014-9573-9","article-title":"Elevated cerebral lactate: Implications in the pathogenesis of hepatic encephalopathy","volume":"29","author":"Bosoi","year":"2014","journal-title":"Metab Brain Dis."},{"key":"B142","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1136\/jnnp-2014-308577","article-title":"CSF lactate levels, \u03c4 proteins, cognitive decline: a dynamic relationship in Alzheimer's disease","volume":"86","author":"Liguori","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B143","doi-asserted-by":"publisher","first-page":"e12924","DOI":"10.1111\/acel.12924","article-title":"Systems biology identifies preserved integrity but impaired metabolism of mitochondria due to a glycolytic defect in Alzheimer's disease neurons","volume":"18","author":"Theurey","year":"2019","journal-title":"Aging Cell."},{"key":"B144","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00401-020-02152-8","article-title":"Biological sex and DNA repair deficiency drive Alzheimer's disease via systemic metabolic remodeling and brain mitochondrial dysfunction","volume":"140","author":"Demarest","year":"2020","journal-title":"Acta Neuropathol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.15252\/embj.201796797","article-title":"Increased localization of APP -C99 in mitochondria-associated ER membranes causes mitochondrial dysfunction in Alzheimer disease","volume":"36","author":"Pera","year":"2017","journal-title":"EMBO J."},{"key":"B146","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1101\/gr.269381.120","article-title":"Blood-derived mitochondrial DNA copy number is associated with gene expression across multiple tissues and is predictive for incident neurodegenerative disease","volume":"31","author":"Yang","year":"2021","journal-title":"Genome Res."},{"key":"B147","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3233\/JAD-131715","article-title":"Mitochondrial DNA copy numbers in pyramidal neurons are decreased and mitochondrial biogenesis transcriptome signaling is disrupted in alzheimer's disease Hippocampi","volume":"40","author":"Rice","year":"2014","journal-title":"J Alzheimers Dis."},{"key":"B148","doi-asserted-by":"publisher","first-page":"5923938","DOI":"10.1155\/2016\/5923938","article-title":"Mitochondrial alterations in peripheral mononuclear blood cells from alzheimer's disease and mild cognitive impairment patients","volume":"2016","author":"Delbarba","year":"2016","journal-title":"Oxid Med Cell Longev."},{"key":"B149","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/1873-3468.14021","article-title":"Mitochondrial DNA copy number in human disease: the more the better?","volume":"595","author":"Filograna","year":"2020","journal-title":"FEBS Lett."},{"key":"B150","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1080\/17460441.2020.1674808","article-title":"Recent advances from metabolomics and lipidomics application in alzheimer's disease inspiring drug discovery","volume":"15","author":"Cuperlovic-Culf","year":"2019","journal-title":"Expert Opin Drug Discov."},{"key":"B151","doi-asserted-by":"publisher","first-page":"101987","DOI":"10.1016\/j.arr.2023.101987","article-title":"Integrative metabolomics science in Alzheimer's disease: relevance and future perspectives","volume":"89","author":"Lista","year":"2023","journal-title":"Ageing Res Rev"},{"key":"B152","doi-asserted-by":"publisher","first-page":"e1002482","DOI":"10.1371\/journal.pmed.1002482","article-title":"Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: a targeted metabolomics study","volume":"15","author":"Varma","year":"2018","journal-title":"PLoS Med."},{"key":"B153","doi-asserted-by":"publisher","first-page":"1096206","DOI":"10.3389\/fnagi.2023.1096206","article-title":"White matter injury, cholesterol dysmetabolism, and APP\/Abeta dysmetabolism interact to produce Alzheimer's disease (AD) neuropathology: a hypothesis and review","volume":"15","author":"Sharp","year":"2023","journal-title":"Front Aging Neurosci."},{"key":"B154","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3390\/biomedicines13020279","article-title":"Beyond Amyloid and TAU: The critical role of Microglia in Alzheimer's disease therapeutics","volume":"13","author":"Dias","year":"2025","journal-title":"Biomedicines."},{"key":"B155","doi-asserted-by":"publisher","first-page":"ENEURO","DOI":"10.1523\/ENEURO.0088-24.2024","article-title":"What's in it for me? Contextualizing the potential clinical impacts of lecanemab, donanemab, and other anti-B-amyloid monoclonal antibodies in early Alzheimer's disease","volume":"11","author":"Jin","year":"2024","journal-title":"eNeuro"},{"key":"B156","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1002\/alz.13449","article-title":"The Alzheimer's disease neuroimaging initiative in the era of Alzheimer's disease treatment: a review of ADNI studies from 2021 to 2022","volume":"20","author":"Veitch","year":"2023","journal-title":"Alzheimers Dement."},{"key":"B157","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40142-018-0132-2","article-title":"Mitochondria and Alzheimer's disease: the role of mitochondrial genetic variation","volume":"6","author":"Ridge","year":"2018","journal-title":"Curr Genet Med Rep."},{"key":"B158","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-94-007-2869-1_2","article-title":"Physiology and pathophysiology of mitochondrial DNA","volume":"942","author":"Li","year":"2011","journal-title":"Adv Exp Med Biol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1002\/alz.12119","article-title":"Exploratory analysis of mtDNA haplogroups in two Alzheimer's longitudinal cohorts","volume":"16","author":"Swerdlow","year":"2020","journal-title":"Alzheimers Dement."},{"key":"B160","doi-asserted-by":"publisher","first-page":"13258","DOI":"10.3390\/ijms222413258","article-title":"In vitro comparative study of solid lipid and PLGA nanoparticles designed to facilitate Nose-to-Brain delivery of insulin","volume":"22","author":"Akel","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B161","doi-asserted-by":"publisher","first-page":"e13113","DOI":"10.1111\/acel.13113","article-title":"TRPV1 activation alleviates cognitive and synaptic plasticity impairments through inhibiting AMPAR endocytosis in APP23\/PS45 mouse model of Alzheimer's disease","volume":"19","author":"Du","year":"2020","journal-title":"Aging Cell."},{"key":"B162","doi-asserted-by":"publisher","first-page":"431","DOI":"10.14670\/HH-18-421","article-title":"Histopathological evaluation of insulin-DMSO formula designed for direct nose-to-brain delivery","volume":"37","author":"Maher","year":"2022","journal-title":"Histol Histopathol."},{"key":"B163","doi-asserted-by":"publisher","first-page":"111812","DOI":"10.1016\/j.exger.2022.111812","article-title":"MicroRNA modulation is a potential molecular mechanism for neuroprotective effects of intranasal insulin administration in amyloid \u03b2eta oligomer induced Alzheimer's like rat model","volume":"164","author":"Bazrgar","year":"2022","journal-title":"Exp Gerontol"},{"key":"B164","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/npp.2015.312","article-title":"Central nervous insulin signaling in sleep-associated memory formation and neuroendocrine regulation","volume":"41","author":"Feld","year":"2015","journal-title":"Neuropsychopharmacology."},{"key":"B165","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1210\/jc.2014-3018","article-title":"Central Insulin Administration improves Odor-Cued reactivation of spatial memory in young men","volume":"100","author":"Br\u00fcnner","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"key":"B166","doi-asserted-by":"publisher","first-page":"580","DOI":"10.3389\/fendo.2018.00580","article-title":"Odor sensitivity after intranasal insulin application is modulated by gender","volume":"9","author":"Rodriguez-Raecke","year":"2018","journal-title":"Front Endocrinol"},{"key":"B167","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1080\/02699052.2019.1587000","article-title":"GLP-1\u2032s role in neuroprotection: a systematic review","volume":"33","author":"Erbil","year":"2019","journal-title":"Brain Injury."},{"key":"B168","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.tem.2016.10.001","article-title":"Glucagon-like peptide-1 and the Central\/Peripheral nervous System: crosstalk in diabetes","volume":"28","author":"Muscogiuri","year":"2016","journal-title":"Trends Endocrinol Metab."},{"key":"B169","doi-asserted-by":"publisher","first-page":"T31","DOI":"10.1530\/JOE-13-0221","article-title":"Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases","volume":"221","author":"H\u00f6lscher","year":"2013","journal-title":"J Endocrinol."},{"key":"B170","doi-asserted-by":"publisher","first-page":"e14651","DOI":"10.14814\/phy2.14651","article-title":"Glucagon-like peptide-1 analog improves neuronal and behavioral impairment and promotes neuroprotection in a rat model of aluminum-induced dementia","volume":"8","author":"el-Rady","year":"2020","journal-title":"Physiol Rep"},{"key":"B171","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s40263-018-0593-6","article-title":"Neuroprotective actions of glucagon-like peptide-1 (GLP-1) analogues in Alzheimer's and Parkinson's diseases","volume":"33","author":"Batista","year":"2018","journal-title":"CNS Drugs."},{"key":"B172","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1124\/pr.115.011395","article-title":"Glucagon-Like peptide-1 and its class B G protein\u2013coupled receptors: a long march to therapeutic successes","volume":"68","author":"De Graaf","year":"2016","journal-title":"Pharmacol Rev."},{"key":"B173","doi-asserted-by":"publisher","first-page":"7749","DOI":"10.1111\/ejn.15502","article-title":"Potential new therapeutic target for Alzheimer's disease: glucagon-like peptide-1","volume":"54","author":"Liu","year":"2021","journal-title":"Eur J Neurosci."},{"key":"B174","doi-asserted-by":"publisher","first-page":"e0158205","DOI":"10.1371\/journal.pone.0158205","article-title":"Long-term treatment with liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has no effect on \u03b2-amyloid plaque load in two transgenic APP\/PS1 mouse models of Alzheimer's disease","volume":"11","author":"Hansen","year":"2016","journal-title":"PLoS ONE."},{"key":"B175","doi-asserted-by":"publisher","first-page":"e44763","DOI":"10.7759\/cureus.44763","article-title":"Exploring the potential of antidiabetic agents as therapeutic approaches for Alzheimer's and Parkinson's diseases: a comprehensive review","volume":"15","author":"Koshatwar","year":"2023","journal-title":"Cureus."},{"key":"B176","doi-asserted-by":"publisher","first-page":"777","DOI":"10.3233\/ADR-230181","article-title":"Clinical evidence for GLP-1 receptor agonists in Alzheimer's disease: a systematic review","volume":"8","author":"Liang","year":"2024","journal-title":"J Alzheimers Dis Rep."},{"key":"B177","doi-asserted-by":"publisher","first-page":"83","DOI":"10.31887\/DCNS.2019.21.1\/bbendlin","article-title":"Antidiabetic therapies and Alzheimer disease","volume":"21","author":"Bendlin","year":"2019","journal-title":"Dialogues Clin Neurosci."},{"key":"B178","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1007\/s11095-017-2199-y","article-title":"Metformin \u2013 a future therapy for neurodegenerative diseases","volume":"34","author":"Markowicz-Piasecka","year":"2017","journal-title":"Pharm Res."},{"key":"B179","doi-asserted-by":"publisher","first-page":"6337","DOI":"10.7150\/thno.44962","article-title":"Dysregulated expression of monoacylglycerol lipase is a marker for anti-diabetic drug metformin-targeted therapy to correct impaired neurogenesis and spatial memory in Alzheimer's disease","volume":"10","author":"Syal","year":"2020","journal-title":"Theranostics."},{"key":"B180","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3233\/JAD-141332","article-title":"Metformin treatment alters memory function in a mouse model of Alzheimer's disease","volume":"44","author":"DiTacchio","year":"2015","journal-title":"J Alzheimers Dis."},{"key":"B181","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.3233\/JAD-181240","article-title":"Metformin improves learning and memory in the SAMP8 mouse model of Alzheimer's disease","volume":"68","author":"Farr","year":"2019","journal-title":"J Alzheimers Dis."},{"key":"B182","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.bbi.2017.12.009","article-title":"Metformin treatment prevents amyloid plaque deposition and memory impairment in APP\/PS1 mice","volume":"69","author":"Ou","year":"2017","journal-title":"Brain Behav Immun"},{"key":"B183","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/WAD.0000000000000202","article-title":"Effects of the insulin sensitizer metformin in Alzheimer disease","volume":"31","author":"Koenig","year":"2017","journal-title":"Alzheimer Dis Assoc Disord."},{"key":"B184","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/ggi.13692","article-title":"Taking metformin and cognitive function change in older patients with diabetes","volume":"19","author":"Koo","year":"2019","journal-title":"Geriatr Gerontol Int."},{"key":"B185","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.3233\/JAD-220180","article-title":"Association between metformin and Alzheimer's disease: a systematic review and meta-analysis of clinical observational studies","volume":"88","author":"Luo","year":"2022","journal-title":"J Alzheimers Dis."},{"key":"B186","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.2337\/dc13-0229","article-title":"Increased risk of cognitive impairment in patients with diabetes is associated with metformin","volume":"36","author":"Moore","year":"2013","journal-title":"Diabetes Care."},{"key":"B187","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1210\/jc.2015-3754","article-title":"Long-term metformin use and vitamin B12 deficiency in the diabetes prevention program outcomes study","volume":"101","author":"Aroda","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"key":"B188","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.freeradbiomed.2014.03.003","article-title":"The mitochondria-targeted antioxidant MitoQ extends lifespan and improves healthspan of a transgenic Caenorhabditis elegans model of Alzheimer disease","volume":"71","author":"Ng","year":"2014","journal-title":"Free Radic Biol Med"},{"key":"B189","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.3390\/ijms24043739","article-title":"Mitochondria-targeted antioxidants, an innovative class of antioxidant compounds for neurodegenerative diseases: perspectives and limitations","volume":"24","author":"Fields","year":"2023","journal-title":"Int J Mol Sci."},{"key":"B190","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1134\/S000629791712001X","article-title":"Programmed aging of mammals: Proof of concept and prospects of biochemical approaches for anti-aging therapy","volume":"82","author":"Skulachev","year":"2017","journal-title":"Biochemistry."},{"key":"B191","doi-asserted-by":"publisher","first-page":"174","DOI":"10.2741\/e794","article-title":"Associations of Alzheimer's disease with macular degeneration","volume":"9","author":"Biscetti","year":"2017","journal-title":"Front Biosci"},{"key":"B192","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3390\/antiox8060177","article-title":"Suppression of AMD-like pathology by mitochondria-targeted antioxidant SkQ1 is associated with a decrease in the accumulation of amyloid \u03b2 and in mTOR activity","volume":"8","author":"Muraleva","year":"2019","journal-title":"Antioxidants."},{"key":"B193","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1134\/S0006297914100113","article-title":"Preventive and therapeutic effects of SkQ1-containing visomitin eye drops against light-induced retinal degeneration","volume":"79","author":"Novikova","year":"2014","journal-title":"Biochemistry."},{"key":"B194","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/2082561","article-title":"Therapeutic effect of the mitochondria-targeted antioxidant SKQ1 on the culture model of multiple sclerosis","volume":"2019","author":"Fetisova","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"B195","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/clpt.2014.174","article-title":"Serendipity and the discovery of novel compounds that restore mitochondrial plasticity","volume":"96","author":"Szeto","year":"2014","journal-title":"Clin Pharmacol Ther."},{"key":"B196","doi-asserted-by":"publisher","first-page":"747901","DOI":"10.3389\/fnint.2021.747901","article-title":"Neuroprotective effects of a small Mitochondrially-Targeted tetrapeptide elamipretide in neurodegeneration","volume":"15","author":"Nhu","year":"2022","journal-title":"Front Integr Neurosci"},{"key":"B197","doi-asserted-by":"publisher","first-page":"e12731","DOI":"10.1111\/acel.12731","article-title":"Treatment with the mitochondrial-targeted antioxidant peptide SS-31 rescues neurovascular coupling responses and cerebrovascular endothelial function and improves cognition in aged mice","volume":"17","author":"Tarantini","year":"2018","journal-title":"Aging Cell."},{"key":"B198","doi-asserted-by":"publisher","first-page":"E55513","DOI":"10.7554\/eLife.55513.sa2","article-title":"Late-life restoration of mitochondrial function reverses cardiac dysfunction in old mice","volume":"9","author":"Chiao","year":"2020","journal-title":"ELife"},{"key":"B199","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1136\/gutjnl-2020-321548","article-title":"ATF4 activation promotes hepatic mitochondrial dysfunction by repressing NRF1\u2013TFAM signalling in alcoholic steatohepatitis","volume":"70","author":"Hao","year":"2020","journal-title":"Gut."},{"key":"B200","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature23275","article-title":"Fructose-1,6-bisphosphate and aldolase mediate glucose sensing by AMPK","volume":"548","author":"Zhang","year":"2017","journal-title":"Nature."},{"key":"B201","doi-asserted-by":"publisher","first-page":"671563","DOI":"10.3389\/fphar.2021.671563","article-title":"Nicotinamide riboside enhances endothelial precursor cell function to promote refractory wound healing through mediating the SIRT1\/AMPK pathway","volume":"12","author":"Wang","year":"2021","journal-title":"Front Pharmacol"},{"key":"B202","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.neuron.2016.12.017","article-title":"Role of mitochondrial metabolism in the control of early lineage progression and aging phenotypes in adult hippocampal neurogenesis","volume":"93","author":"Beckervordersandforth","year":"2017","journal-title":"Neuron"},{"key":"B203","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1093\/hmg\/ddy154","article-title":"Mutant APP and amyloid beta-induced defective autophagy, mitophagy, mitochondrial structural and functional changes and synaptic damage in hippocampal neurons from Alzheimer's disease","volume":"27","author":"Reddy","year":"2018","journal-title":"Hum Mol Genet."},{"key":"B204","doi-asserted-by":"publisher","first-page":"135598","DOI":"10.1016\/j.neulet.2020.135598","article-title":"PGC-1\u03b1 reduces Amyloid-\u03b2 deposition in Alzheimer's disease: Effect of increased VDR expression","volume":"744","author":"Wang","year":"2020","journal-title":"Neurosci Lett"},{"key":"B205","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/s41573-021-00217-1","article-title":"Exercise mimetics: harnessing the therapeutic effects of physical activity","volume":"20","author":"Gubert","year":"2021","journal-title":"Nat Rev Drug Discov."},{"key":"B206","doi-asserted-by":"publisher","first-page":"636","DOI":"10.3389\/fphys.2018.00636","article-title":"Moderate exercise suppresses NF-\u03baB signaling and activates the SIRT1-AMPK-PGC1\u03b1 axis to attenuate muscle loss in diabetic db\/db Mice","volume":"9","author":"Liu","year":"2018","journal-title":"Front Physiol"},{"key":"B207","doi-asserted-by":"publisher","first-page":"860364","DOI":"10.3389\/fnagi.2022.860364","article-title":"Potential mechanism underlying exercise upregulated circulating blood exosome MIR-215-5P to prevent necroptosis of neuronal cells and a model for early diagnosis of Alzheimer's disease","volume":"14","author":"Chen","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"B208","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/jnc.15362","article-title":"Sex-specific alterations in NAD+ metabolism in 3xTg Alzheimer's disease mouse brain assessed by quantitative targeted LC-MS","volume":"159","author":"Van Der Velpen","year":"2021","journal-title":"J Neurochem."},{"key":"B209","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1007\/s12031-021-01842-6","article-title":"Protective effects of nicotinamide adenine dinucleotide and related precursors in Alzheimer's disease: a systematic review of preclinical studies","volume":"71","author":"Hosseini","year":"2021","journal-title":"J Mol Neurosci."},{"key":"B210","doi-asserted-by":"publisher","first-page":"e2011226118","DOI":"10.1073\/pnas.2011226118","article-title":"NAD + supplementation reduces neuroinflammation and cell senescence in a transgenic mouse model of Alzheimer's disease via cGAS\u2013STING","volume":"118","author":"Hou","year":"2021","journal-title":"Proc Nat Acad Sci."},{"key":"B211","doi-asserted-by":"publisher","first-page":"S467","DOI":"10.3233\/JAD-231277","article-title":"Supplementation with NAD+ precursors for treating alzheimer's disease: a metabolic approach","volume":"101","author":"Alghamdi","year":"2024","journal-title":"J Alzheimers Dis."},{"key":"B212","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.neurobiolaging.2016.08.005","article-title":"A ketogenic diet accelerates neurodegeneration in mice with induced mitochondrial DNA toxicity in the forebrain","volume":"48","author":"Lauritzen","year":"2016","journal-title":"Neurobiol Aging"},{"key":"B213","doi-asserted-by":"publisher","first-page":"e75713","DOI":"10.1371\/journal.pone.0075713","article-title":"Ketogenic diet improves motor performance but not cognition in two mouse models of Alzheimer's pathology","volume":"8","author":"Brownlow","year":"2013","journal-title":"PLoS ONE."},{"key":"B214","doi-asserted-by":"publisher","first-page":"702802","DOI":"10.3389\/fnut.2021.702802","article-title":"Ketogenic diets and chronic disease: weighing the benefits against the risks","volume":"8","author":"Crosby","year":"2021","journal-title":"Front Nutr"},{"key":"B215","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13195-021-00783-x","article-title":"Randomized crossover trial of a modified ketogenic diet in Alzheimer's disease","volume":"13","author":"Phillips","year":"2021","journal-title":"Alzheimers Res Ther."},{"key":"B216","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.3390\/ijms20163892","article-title":"Ketogenic diet in Alzheimer's disease","volume":"20","author":"Rusek","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B217","doi-asserted-by":"publisher","first-page":"111209","DOI":"10.1016\/j.mad.2020.111209","article-title":"Potential of coconut oil and medium chain triglycerides in the prevention and treatment of Alzheimer's disease","volume":"186","author":"Chatterjee","year":"2020","journal-title":"Mech Ageing Dev"},{"key":"B218","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1093\/nutrit\/nuac104","article-title":"Medium-chain fatty acids for the prevention or treatment of Alzheimer's disease: a systematic review and meta-analysis","volume":"81","author":"Castro","year":"2023","journal-title":"Nutr Rev."},{"key":"B219","doi-asserted-by":"publisher","first-page":"101001","DOI":"10.1016\/j.arr.2019.101001","article-title":"Medium chain triglycerides induce mild ketosis and may improve cognition in Alzheimer's disease. A systematic review and meta-analysis of human studies","volume":"58","author":"Avgerinos","year":"2019","journal-title":"Ageing Res Rev"},{"key":"B220","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.molmed.2021.04.009","article-title":"Impact of the natural compound urolithin A on health, disease, and aging","volume":"27","author":"D'Amico","year":"2021","journal-title":"Trends Mol Med."},{"key":"B221","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1089\/rej.2018.2066","article-title":"Antiaging effects of urolithin A on replicative senescent human skin fibroblasts","volume":"22","author":"Liu","year":"2018","journal-title":"Rejuvenation Res."},{"key":"B222","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/nm.4132","article-title":"Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents","volume":"22","author":"Ryu","year":"2016","journal-title":"Nat Med."},{"key":"B223","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1007\/s12035-023-03651-x","article-title":"Urolithin A prevents sleep-deprivation-induced neuroinflammation and mitochondrial dysfunction in young and aged mice","volume":"61","author":"Misrani","year":"2023","journal-title":"Mol Neurobiol."},{"key":"B224","doi-asserted-by":"publisher","first-page":"4212","DOI":"10.1002\/alz.13847","article-title":"Urolithin A improves Alzheimer's disease cognition and restores mitophagy and lysosomal functions","volume":"20","author":"Hou","year":"2024","journal-title":"Alzheimers Dement."},{"key":"B225","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fchem.2018.00010","article-title":"Polyamines: bio-molecules with diverse functions in plant and human health and disease","volume":"6","author":"Handa","year":"2018","journal-title":"Front Chem"},{"key":"B226","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1080\/15548627.2021.1933299","article-title":"Spermidine-induced hypusination preserves mitochondrial and cognitive function during aging","volume":"17","author":"Hofer","year":"2021","journal-title":"Autophagy."},{"key":"B227","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1159\/000356748","article-title":"Molecular basis of the \u2018anti-aging' effect of spermidine and other natural polyamines - a mini-review","volume":"60","author":"Minois","year":"2014","journal-title":"Gerontology."},{"key":"B228","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.exger.2018.04.005","article-title":"Spermidine ameliorates the neuronal aging by improving the mitochondrial function in vitro","volume":"108","author":"Jing","year":"2018","journal-title":"Exp Gerontol"},{"key":"B229","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12974-022-02534-7","article-title":"Spermidine reduces neuroinflammation and soluble amyloid beta in an alzheimer's disease mouse model","volume":"19","author":"Freitag","year":"2022","journal-title":"J Neuroinflamm."},{"key":"B230","doi-asserted-by":"publisher","first-page":"e2213875","DOI":"10.1001\/jamanetworkopen.2022.13875","article-title":"Effects of spermidine supplementation on cognition and biomarkers in older adults with subjective cognitive decline","volume":"5","author":"Schwarz","year":"2022","journal-title":"JAMA Network Open."},{"key":"B231","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1126\/science.1244360","article-title":"MTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome","volume":"342","author":"Johnson","year":"2013","journal-title":"Science."},{"key":"B232","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.nbd.2015.10.001","article-title":"mTOR pathway inhibition prevents neuroinflammation and neuronal death in a mouse model of cerebral palsy","volume":"85","author":"Srivastava","year":"2015","journal-title":"Neurobiol Dis"},{"key":"B233","doi-asserted-by":"publisher","first-page":"e0142340","DOI":"10.1371\/journal.pone.0142340","article-title":"The MTOR inhibitor rapamycin mitigates perforant pathway neurodegeneration and synapse loss in a mouse model of Early-Stage Alzheimer-Type tauopathy","volume":"10","author":"Siman","year":"2015","journal-title":"PLoS ONE."},{"key":"B234","doi-asserted-by":"publisher","first-page":"eaar4289","DOI":"10.1126\/scitranslmed.aar4289","article-title":"Rapamycin and Alzheimer's disease: Time for a clinical trial?","volume":"11","author":"Kaeberlein","year":"2019","journal-title":"Sci Transl Med"},{"key":"B235","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1080\/15548627.2019.1615823","article-title":"Rapamycin and Alzheimer disease: a double-edged sword?","volume":"15","author":"Carosi","year":"2019","journal-title":"Autophagy."},{"key":"B236","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3389\/fnins.2020.00775","article-title":"MTOR mysteries: nuances and questions about the mechanistic target of rapamycin in neurodegeneration","volume":"14","author":"Norwitz","year":"2020","journal-title":"Front Neurosci"},{"key":"B237","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/gerona\/glw090","article-title":"Rapamycin: an InhibiTOR of aging emerges from the soil of Easter Island","volume":"71","author":"Apelo","year":"2016","journal-title":"J Gerontol Ser A."},{"key":"B238","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.bbi.2013.11.014","article-title":"Calorie restriction attenuates lipopolysaccharide (LPS)-induced microglial activation in discrete regions of the hypothalamus and the subfornical organ","volume":"38","author":"Radler","year":"2013","journal-title":"Brain Behav Immun"},{"key":"B239","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s00335-016-9647-6","article-title":"Caloric restriction: beneficial effects on brain aging and Alzheimer's disease","volume":"27","author":"Van Cauwenberghe","year":"2016","journal-title":"Mamm Genome."},{"key":"B240","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/ageing\/afu055","article-title":"Effects of functional tasks exercise on older adults with cognitive impairment at risk of Alzheimer's disease: a randomised controlled trial","volume":"43","author":"Law","year":"2014","journal-title":"Age Ageing."},{"key":"B241","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3233\/JAD-170014","article-title":"Effects of exercise on cognitive function in older people with dementia: a randomized controlled trial","volume":"60","author":"Toots","year":"2017","journal-title":"J Alzheimers Dis."},{"key":"B242","doi-asserted-by":"publisher","first-page":"e0121478","DOI":"10.1371\/journal.pone.0121478","article-title":"Effects of physical activity training in patients with alzheimer's dementia: results of a pilot RCT study","volume":"10","author":"Holthoff","year":"2015","journal-title":"PLoS ONE."},{"key":"B243","doi-asserted-by":"publisher","first-page":"112488","DOI":"10.1016\/j.bbr.2020.112488","article-title":"Exercise effects on brain and behavior in healthy mice, Alzheimer's disease and Parkinson's disease model\u2014a systematic review and meta-analysis","volume":"383","author":"Da Costa Daniele","year":"2020","journal-title":"Behav Brain Res"},{"key":"B244","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta22280","article-title":"Aerobic and strength training exercise programme for cognitive impairment in people with mild to moderate dementia: the DAPA RCT","volume":"22","author":"Lamb","year":"2018","journal-title":"Health Technol Assess."},{"key":"B245","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/jgs.15241","article-title":"Can exercise improve cognitive symptoms of Alzheimer's disease?","volume":"66","author":"Panza","year":"2018","journal-title":"J Am Geriatr Soc."},{"key":"B246","doi-asserted-by":"publisher","first-page":"e0170547","DOI":"10.1371\/journal.pone.0170547","article-title":"Aerobic exercise for Alzheimer's disease: a randomized controlled pilot trial","volume":"12","author":"Morris","year":"2017","journal-title":"PLoS ONE."},{"key":"B247","doi-asserted-by":"publisher","first-page":"111617","DOI":"10.1016\/j.exger.2021.111617","article-title":"The effects of intermittent fasting regimens in middle-age and older adults: Current state of evidence","volume":"156","author":"Anton","year":"2021","journal-title":"Exp Gerontol."},{"key":"B248","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrn.2017.156","article-title":"Intermittent metabolic switching, neuroplasticity and brain health","volume":"19","author":"Mattson","year":"2018","journal-title":"Nat Rev Neurosci."},{"key":"B249","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1002\/jmv.26895","article-title":"A pilot double-blind safety and feasibility randomized controlled trial of high-dose intravenous zinc in hospitalized COVID-19 patients","volume":"93","author":"Patel","year":"2021","journal-title":"J Med Virol."},{"key":"B250","first-page":"139","volume-title":"Contribution of Mediterranean Diet in the Prevention of Alzheimer's Disease","author":"Panza","year":"2018"},{"key":"B251","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3233\/JAD-130830","article-title":"Association of mediterranean diet with mild cognitive impairment and alzheimer's disease: a systematic review and meta-analysis","volume":"39","author":"Singh","year":"2014","journal-title":"J Alzheimers Dis."},{"key":"B252","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.jalz.2014.11.009","article-title":"MIND diet associated with reduced incidence of Alzheimer's disease","volume":"11","author":"Morris","year":"2015","journal-title":"Alzheimers Dement."},{"key":"B253","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1037\/neu0000373","article-title":"A lower ratio of omega-6 to omega-3 fatty acids predicts better hippocampus-dependent spatial memory and cognitive status in older adults","volume":"31","author":"Andruchow","year":"2017","journal-title":"Neuropsychology."},{"key":"B254","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.jacl.2019.08.003","article-title":"Review of current evidence and clinical recommendations on the effects of low-carbohydrate and very-low-carbohydrate (including ketogenic) diets for the management of body weight and other cardiometabolic risk factors: a scientific statement from the National Lipid Association Nutrition and Lifestyle Task Force","volume":"13","author":"Kirkpatrick","year":"2019","journal-title":"J Clin Lipidol"},{"key":"B255","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ijpharm.2015.07.011","article-title":"Drug-in-cyclodextrin-in-liposomes: A novel drug delivery system for flurbiprofen","volume":"492","author":"Zhang","year":"2015","journal-title":"Int J Pharm."},{"key":"B256","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3390\/molecules26010080","article-title":"First synthesis of racemic trans Propargylamino-Donepezil, a Pleiotrope agent able to both inhibit AChE and MAO-B, with potential interest against Alzheimer's disease","volume":"26","author":"Guieu","year":"2020","journal-title":"Molecules."},{"key":"B257","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/alz.12450","article-title":"The costs of developing treatments for Alzheimer's disease: a retrospective exploration","volume":"18","author":"Cummings","year":"2021","journal-title":"Alzheimers Dement."},{"key":"B258","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1212\/WNL.0000000000009236","article-title":"Mitochondria in Alzheimer brains","volume":"94","author":"Swerdlow","year":"2020","journal-title":"Neurology."},{"key":"B259","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1007\/s00330-015-3696-1","article-title":"Cerebral perfusion and glucose metabolism in Alzheimer's disease and frontotemporal dementia: two sides of the same coin?","volume":"25","author":"Verfaillie","year":"2015","journal-title":"Eur Radiol."},{"key":"B260","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/jnr.23777","article-title":"Cerebral hypoperfusion and glucose hypometabolism: key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease","volume":"95","author":"Daulatzai","year":"2016","journal-title":"J Neurosci Res."},{"key":"B261","unstructured":"Alzheimer's Disease Research Models\n          \n          2023"},{"key":"B262","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-181121","article-title":"The Alzheimer Precision Medicine Initiative","volume":"68","author":"Hampel","year":"2019","journal-title":"J Alzheimers Dis."},{"key":"B263","doi-asserted-by":"publisher","first-page":"107","DOI":"10.21037\/atm.2016.03.05","article-title":"Toward precision medicine in Alzheimer's disease","volume":"4","author":"Reitz","year":"2016","journal-title":"Ann Transl Med."},{"key":"B264","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/978-1-4939-2627-5_2","article-title":"Application of systems theory in longitudinal studies on the origin and progression of Alzheimer's disease","volume":"1303","author":"Lista","year":"2015","journal-title":"Methods Mol Biol"},{"key":"B265","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.ccell.2022.08.011","article-title":"Clinical application of advanced multi-omics tumor profiling: shaping precision oncology of the future","volume":"40","author":"Akhoundova","year":"2022","journal-title":"Cancer Cell."},{"key":"B266","doi-asserted-by":"publisher","first-page":"766082","DOI":"10.3389\/fphar.2021.766082","article-title":"Multi-omics analysis of microglial extracellular vesicles from human Alzheimer's disease brain tissue reveals Disease-Associated signatures","volume":"12","author":"Cohn","year":"2021","journal-title":"Front Pharmacol"},{"key":"B267","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jalz.2016.09.014","article-title":"Blood-based biomarkers in Alzheimer disease: current state of the science and a novel collaborative paradigm for advancing from discovery to clinic","volume":"13","author":"O'Bryant","year":"2016","journal-title":"Alzheimers Dement."},{"key":"B268","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41582-018-0079-7","article-title":"Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic","volume":"14","author":"Hampel","year":"2018","journal-title":"Nat Rev Neurol."},{"key":"B269","doi-asserted-by":"publisher","first-page":"783713","DOI":"10.3389\/fgene.2021.783713","article-title":"PathwayMultiomics: an R package for efficient integrative analysis of Multi-Omics datasets with matched or un-matched samples","volume":"12","author":"Odom","year":"2021","journal-title":"Front Genet"},{"key":"B270","doi-asserted-by":"publisher","first-page":"bbab121","DOI":"10.1093\/bib\/bbab121","article-title":"Integrative-omics for discovery of network-level disease biomarkers: a case study in Alzheimer's disease","volume":"22","author":"Xie","year":"2021","journal-title":"Brief Bioinform."},{"key":"B271","doi-asserted-by":"publisher","first-page":"1556427","DOI":"10.3389\/fneur.2025.1556427","article-title":"Brain glucose metabolism in patients with traumatic brain injury undergoing rehabilitation: a longitudinal 18F-FDG PET study","volume":"16","author":"Pingue","year":"2025","journal-title":"Front Neurol"},{"key":"B272","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13195-022-01004-9","article-title":"Cerebrospinal fluid lactate levels along the Alzheimer's disease continuum and associations with blood-brain barrier integrity, age, cognition, and biomarkers","volume":"14","author":"Zebhauser","year":"2022","journal-title":"Alzheimers Res Ther."},{"key":"B273","doi-asserted-by":"publisher","first-page":"10911","DOI":"10.3390\/ijms252010911","article-title":"Blood-based biomarkers in Alzheimer's disease: advancing non-invasive diagnostics and prognostics","volume":"25","author":"Dhauria","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B274","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.3390\/biomedicines11112897","article-title":"and Gambini, J. Oxidative stress, atherogenic dyslipidemia, and cardiovascular risk","volume":"11","author":"Vekic","year":"2023","journal-title":"Biomedicines."},{"key":"B275","doi-asserted-by":"publisher","first-page":"4436","DOI":"10.1002\/alz.13388","article-title":"Skeletal muscle mitochondrial function predicts cognitive impairment and is associated with biomarkers of Alzheimer's disease and neurodegeneration","volume":"19","author":"Tian","year":"2023","journal-title":"Alzheimers Dement."},{"key":"B276","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/alz.12683","article-title":"The role of mitochondrial dysfunction in Alzheimer's disease pathogenesis","volume":"19","author":"Ashleigh","year":"2023","journal-title":"Alzheimers Dement."},{"key":"B277","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.3390\/antiox10091353","article-title":"and Galimberti, D. Role of oxidative damage in Alzheimer's disease and neurodegeneration: From pathogenic mechanisms to biomarker discovery","volume":"10","author":"Buccellato","year":"2021","journal-title":"Antioxidants."},{"key":"B278","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.3390\/antiox11112167","article-title":"The link between oxidative stress, mitochondrial dysfunction and neuroinflammation in the pathophysiology of Alzheimer's disease: therapeutic implications and future perspectives","volume":"11","author":"Jurc\u0103u","year":"2022","journal-title":"Antioxidants."},{"key":"B279","doi-asserted-by":"publisher","first-page":"102694","DOI":"10.1016\/j.conb.2023.102694","article-title":"Metabolic defects shared by Alzheimer's disease and diabetes: a focus on mitochondria","volume":"79","author":"Carvalho","year":"2023","journal-title":"Curr Opin Neurobiol."},{"key":"B280","doi-asserted-by":"publisher","first-page":"6785","DOI":"10.1007\/s12035-024-04468-y","article-title":"Exploring the mechanisms and therapeutic approaches of mitochondrial dysfunction in Alzheimer's disease: an educational literature review","volume":"62","author":"Moawad","year":"2025","journal-title":"Mol Neurobiol."},{"key":"B281","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.3390\/biom12111676","article-title":"Linking the amyloid, tau, and mitochondrial hypotheses of Alzheimer's disease and identifying promising drug targets","volume":"12","author":"Fi\u0161ar","year":"2022","journal-title":"Biomolecules."},{"key":"B282","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1002\/alz.12731","volume":"19","author":"Mahapatra","year":"2023","journal-title":"Alzheimers Dement."},{"key":"B283","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41420-023-01732-3","article-title":"Decoding metabolic signatures in Alzheimer's disease: a mitochondrial perspective","volume":"9","author":"Bano","year":"2023","journal-title":"Cell Death Discov."},{"key":"B284","doi-asserted-by":"publisher","first-page":"675","DOI":"10.2174\/1570159X19666210517114016","article-title":"and Singh, V. Mitochondrial dysfunction in Alzheimer's disease: opportunities for drug development","volume":"20","author":"Bhatia","year":"2022","journal-title":"Curr Neuropharmacol."},{"key":"B285","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1134\/S0006297921060055","article-title":"Mitochondrial disorders in Alzheimer's disease","volume":"86","author":"Sukhorukov","year":"2021","journal-title":"Biochemistry."},{"key":"B286","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.3390\/ijms23073785","article-title":"Brain metabolic alterations in Alzheimer's disease","volume":"23","author":"Ardanaz","year":"2022","journal-title":"Int J Mol Sci."},{"key":"B287","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1002\/alz.12714","article-title":"The landscape of metabolic brain alterations in Alzheimer's disease","volume":"19","author":"Batra","year":"2023","journal-title":"Alzheimer Dement."},{"key":"B288","doi-asserted-by":"publisher","first-page":"9540","DOI":"10.3390\/ijms23179540","article-title":"Dysfunctional glucose metabolism in Alzheimer's disease onset and potential pharmacological interventions","volume":"23","author":"Kumar","year":"2022","journal-title":"Int J Mol Sci."},{"key":"B289","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1007\/s12035-021-02297-x","article-title":"Impact of genetic risk factors for Alzheimer's disease on brain glucose metabolism","volume":"58","author":"Cho","year":"2021","journal-title":"Mol Neurobiol."},{"key":"B290","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.3390\/ijms23052687","article-title":"Alzheimer's disease as type 3 diabetes: common pathophysiological mechanisms between Alzheimer's disease and type 2 diabetes","volume":"23","author":"Michailidis","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B291","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1152\/physrev.00030.2022","article-title":"Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease","volume":"104","author":"Perluigi","year":"2024","journal-title":"Physiol Rev"},{"key":"B292","doi-asserted-by":"publisher","first-page":"5702","DOI":"10.1038\/s41380-021-01068-3","article-title":"Brain cells derived from Alzheimer's disease patients have multiple specific innate abnormalities in energy metabolism Mol Psychiatry","volume":"26","author":"Ryu","year":"2021"},{"key":"B293","doi-asserted-by":"publisher","first-page":"742408","DOI":"10.3389\/fnagi.2022.742408","article-title":"Alzheimer's disease: an update and insights into pathophysiology","volume":"14","author":"Abubakar","year":"2022","journal-title":"Front Aging Neurosci."},{"key":"B294","doi-asserted-by":"publisher","first-page":"1297984","DOI":"10.3389\/fnins.2023.1297984","article-title":"Ketone bodies mediate alterations in brain energy metabolism and biomarkers of Alzheimer's disease","volume":"17","author":"Ramezani","year":"2023","journal-title":"Front Neurosci."},{"key":"B295","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2478\/jtim-2022-0024","article-title":"Aberrant energy metabolism in Alzheimer's disease","volume":"10","author":"Yu","year":"2022","journal-title":"J Transl Int Med."},{"key":"B296","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s11011-021-00673-z","article-title":"Metabolic disorder in Alzheimer's disease","volume":"36","author":"Poddar","year":"2021","journal-title":"Metab Brain Dis."},{"key":"B297","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1186\/s40001-025-02886-9","article-title":"Pathological mechanisms and treatment progression of Alzheimer's disease","volume":"30","author":"Zhang","year":"2025","journal-title":"Eur J Med Res."},{"key":"B298","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1002\/alz.12468","article-title":"Integrative metabolomics-genomics approach reveals key metabolic pathways and regulators of Alzheimer's disease","volume":"18","author":"Horgusluoglu","year":"2022","journal-title":"Alzheimers Dement."},{"key":"B299","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1111\/febs.16344","article-title":"Lipid metabolism and Alzheimer's disease: clinical evidence, mechanistic link and therapeutic promise","volume":"290","author":"Yin","year":"2023","journal-title":"FEBS J."},{"key":"B300","doi-asserted-by":"publisher","first-page":"704","DOI":"10.3390\/diagnostics14070704","article-title":"Neuropathology, neuroimaging, and fluid biomarkers in Alzheimer's disease","volume":"14","author":"Colvee-Martin","year":"2024","journal-title":"Diagnostics."},{"key":"B301","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00401-020-02234-7","article-title":"Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer's disease models and human brains","volume":"141","author":"Vaillant-Beuchot","year":"2021","journal-title":"Acta Neuropathol"},{"key":"B302","doi-asserted-by":"publisher","first-page":"100169","DOI":"10.1016\/j.ahr.2023.100169","article-title":"Mitochondrial dysfunction and oxidative stress in Alzheimer's disease\u2013a step towards mitochondria based therapeutic strategies","volume":"3","author":"Aran","year":"2023","journal-title":"Aging Health Res."},{"key":"B303","doi-asserted-by":"publisher","first-page":"881","DOI":"10.3390\/biomedicines9080881","article-title":"Structural and functional alterations in mitochondria-associated membranes (Mams) and in mitochondria activate stress response mechanisms in an in vitro model of alzheimer's disease","volume":"9","author":"Fernandes","year":"2021","journal-title":"Biomedicines."},{"key":"B304","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13024-020-00376-6","article-title":"Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances","volume":"15","author":"Wang","year":"2020","journal-title":"Mol Neurodegener"},{"key":"B305","doi-asserted-by":"publisher","first-page":"662242","DOI":"10.3389\/fnins.2021.662242","article-title":"Glycolytic metabolism, brain resilience, and Alzheimer's disease","volume":"15","author":"Zhang","year":"2021","journal-title":"Front Neurosci."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1772036\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T05:28:39Z","timestamp":1772083719000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1772036\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":305,"alternative-id":["10.3389\/fneur.2026.1772036"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1772036","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"article-number":"1772036"}}